Endothelin and the heart in health and diseases

T Miyauchi, S Sakai - Peptides, 2019 - Elsevier
Abstract Endothelin-1 (ET-1), a 21-amino acid peptide, was initially identified in 1988 as a
potent vasoconstrictor and pressor substance isolated from the culture supernatant of …

The endothelin family: an overview

T Masaki - Journal of cardiovascular pharmacology, 2000 - journals.lww.com
Endothelin (ET) is a potent vasoconstrictive peptide initially found in the conditioned medium
of cultured endothelial cells (1). It comprises 21 amino acid residues including four cysteine …

Endothelin peptides: biological activities, cellular signalling and clinical significance

J Leppäluoto, H Ruskoaho - Annals of medicine, 1992 - Taylor & Francis
Endothelins (ET-1, ET-2 and ET-3) are a family of 21 amino acid peptides produced by
endothelial cells. They are thought to regulate the local vasomotor tone with endothelium …

Endothelin-a new family of endothelium-derived peptides with widespread biological properties

ACLM de Gouville, HL Lippton, I Cavero, WR Summer… - Life sciences, 1989 - Elsevier
Endothelin (ET) is a novel family of three isopeptides (ET-1, ET-2, ET-3) each containing
twenty-one amino acids and two disulfide bonds. Initially isolated from the supernatant of …

The discovery, the present state, and the future prospects of endothelin

T Masaki - Journal of Cardiovascular Pharmacology, 1989 - journals.lww.com
Endothelin-1 (ET-1) is a potent vasoconstrictive peptide produced by endothelial cells of
blood vessels. This peptide has quite a unique structure and pharmacological properties. ET …

Cardiac endothelin-1 content and receptor subtype in spontaneously hypertensive rats

G Thibault, C Arguin, R Garcia - Journal of molecular and cellular …, 1995 - Elsevier
Endothelin-1 (ET-1), a newly discovered peptide with potent vasoconstrictor and growth-
promoting effects, has been implicated in high blood pressure and cardiac hypertrophy in …

Endothelin-A-receptors in human aorta and pulmonary arteries are downregulated in patients with cardiovascular disease: an adaptive response to increased levels …

RE Kuc, AP Davenport - Journal of Cardiovascular Pharmacology, 2000 - journals.lww.com
Circulating levels of endothelin-1 (ET-1) are elevated in a number of pathophysiological
conditions. Our aim was to determine the effect of overexpression of the peptide on ET …

The endothelin system and its potential as a therapeutic target in cardiovascular disease

GA Gray, DJ Webb - Pharmacology & therapeutics, 1996 - Elsevier
Endothelin (ET)-1, an endothelium-derived peptide, is the most potent vasoconstrictor agent
described to date. ET-1 also has positive inotropic and chronotropic effects in the heart and …

Transgenic rats expressing the human ET-2 gene: a model for the study of endothelin actions in vivo

L Liefeldt, G Schönfelder, W Böcker, B Hocher… - Journal of molecular …, 1999 - Springer
Previous studies have characterized the endothelin peptides (ET-1, ET-2, ET-3) as strong
vasoconstrictors which are possibly involved in the pathogenesis of cardiovascular disease …

The cardiovascular physiology and pharmacology of endothelin-1

E Thorin, M Clozel - Advances in pharmacology, 2010 - Elsevier
One year after the discovery in 1980 that the endothelium was obligatory for acetylcholine to
relax isolated arteries, it was clearly shown that the endothelium could also promote …